Alzheimer disease (AD) is a neurodegenerative disorder characterized clinically by progressive memory loss and subsequent dementia and neuropathologically by senile plaques, neurofibrillary tangles, and synapse loss. Interestingly, a small percentage of individuals with normal antemortem psychometric scores meet the neuropathological criteria for AD (termed 'preclinical' AD (PCAD)). In this study, inferior parietal lobule (IPL) from PCAD and control subjects was compared for oxidative stress markers by immunochemistry, amyloid beta peptide by ELISA, and identification of protein expression differences by proteomics. We observed a significant increase in highly insoluble monomeric Aβ42, but no significant differences in oligomeric Aβ nor in oxidative stress measurements between controls and PCAD subjects. Expression proteomics identified proteins whose trends in PCAD are indicative of cellular protection, possibly correlating with previous studies showing no cell loss in PCAD. Our analyses may reveal processes involved in a period of protection from neurodegeneration that mimic the clinical phenotype of PCAD.
Introduction
Alzheimer disease (AD) is one of the leading causes of death among the elderly. About 50% of persons aged 85 or older are at risk for developing this neurodegenerative disease for which currently there is no cure or prevention. Patients with AD progress from stages of mild memory impairment to complete dementia. A definitive diagnosis of AD is made only after clinically observable symptoms of dementia are accompanied by the postmortem identification of two neuropathological hallmarks: senile plaques (SPs) and neurofibrillary tangles (NFTs), among other indices.
Senile plaques are mainly composed of amyloid beta peptide (Aβ), the latter produced via sequential cleavages of amyloid precursor protein (APP) by beta-and gamma-secretases (Haass et al., 1992; Shoji et al., 1992; Seubert et al., 1992) . Although several peptides of varying length can be formed from these cleavages, research shows that the 42-amino acid Aβ is most toxic, possibly upon self-association into oligomers (Pike et al., 1991; Geula et al., 1998; Li et al., 2009a; Shankar et al., 2008) . Oligomers of Aβ have been heavily implicated in the initiation and pathogenesis of AD, while monomeric forms of Aβ have been suggested to be less harmful, and even neuroprotective. Aβ-mediated oxidative stress, possibly through the Met at position 35, has also been suggested to underlie AD (Butterfield et al., 2010 (Butterfield et al., , 2001 Markesbery, 1999) .
Neurofibrillary tangles consist of hyperphosphorylated tau protein, a microtubule-associated structural protein. Other conditions, such as frontotemporal degeneration and Pick's disease, among others, also contain tau-related deposits (Lee et al., 2001) . Balanced kinasephosphatase reactions regulate the biological function of this protein in neurons; disruption of these events can cause over-phosphorylation of tau, leading to protein breakdown and subsequent development of tangles and dysfunction of anterograde and retrograde transport. Both tau and phosphorylated tau in cerebrospinal fluid (CSF) have been proposed as biomarkers for the prediction and diagnosis of AD in living patients (for tau as a possible biomarker review, see Aluise et al., 2008) .
As mentioned previously, SPs, NFTs, and dementia are all requirements for diagnosis of AD. Adding to the complexity of this disease, brains from a number of cognitively intact individuals at autopsy reveal an extensive SP and NFT load, indicating the possibility of a preclinical or presymptomatic disease state. We have tentatively chosen to define preclinical AD (PCAD) as those individuals with sufficient AD pathological alterations to meet National Institute on Aging-Reagan Institute (NIA-RI) intermediate or, rarely, high likelihood criteria (Braak stage III or higher and moderate or frequent neuritic plaque scores) who had normal cognitive function as shown by antemortem psychometric test scores within the normal range after adjustment for age and education; the classification of these individuals as PCAD is consistent with a 
